EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer

Shiwei Yue, Yunpu Zhang, Wei Zhang

Current Treatment Options in Oncology · 2024

DOI: 10.1007/s11864-024-01243-y ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Treatment Options in Oncology, 2024. Verfasst von Shiwei Yue und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, 430030, Wuhan, C…. Hauptthemen laut MEDLINE: Biliary Tract Neoplasms, Immunotherapy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Opinion Statement Biliary tract cancer (BTC) is a heterogeneous group of aggressive malignancies that arise from the epithelium of the biliary tract. Most patients present with locally advanced or metastatic disease at the time of diagnosis. For patients with unresectable BTC, the survival advantage provided by systemic chemotherapy was limited. Over the last decade, immunotherapy has significantly improved the therapeutic landscape of solid tumors. There is an increasing number of studies evaluating the application of immunotherapy in BTC, including immune checkpoint inhibitors (ICIs), cancer vaccines and adoptive cell therapy. The limited response to ICIs monotherapy in unselected patients prompted investigators to explore different combination therapy strategies. Early clinical trials of therapeutic cancer vaccination and adoptive cell therapy have shown encouraging clinical results. However, there still has been a long way to go via validation of therapeutic efficacy and exploration of strategies to increase the efficacy. Identifying biomarkers that predict the response to immunotherapy will allow a more accurate selection of candidates. This review will provide an up-to-date overview of the current clinical data on the role of immunotherapy, summarize the promising biomarkers predictive of the response to ICIs and discuss the perspective for future research direction of immunotherapy in advanced BTC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biliary Tract NeoplasmsImmunotherapyHumansImmune Checkpoint InhibitorsCombined Modality TherapyBiomarkers, TumorNeoplasm StagingTreatment OutcomeCancer VaccinesDisease ManagementMolecular Targeted TherapyClinical Trials as Topic

Stichwörter der Autor:innen

Adoptive cell therapyBiliary tract cancerCancer vaccinesCheckpoint inhibitorsImmunotherapy

Substanzen

Immune Checkpoint InhibitorsBiomarkers, TumorCancer Vaccines

Autor:innen und Institutionen

  • Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, 430030, Wuhan, China.
  • Hubei Key Laboratory of Hepato‑Pancreatic‑Biliary Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, 430030, Wuhan, China.
  • Clinical Medical Research Center of Hepatic Surgery at Hubei Province, 1095 Jiefang Avenue, 430030, Wuhan, China.
  • Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, 430030, Wuhan, China. weizhangtjh@hust.edu.cn.
  • Hubei Key Laboratory of Hepato‑Pancreatic‑Biliary Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, 430030, Wuhan, China. weizhangtjh@hust.edu.cn.
  • Clinical Medical Research Center of Hepatic Surgery at Hubei Province, 1095 Jiefang Avenue, 430030, Wuhan, China. weizhangtjh@hust.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yue, S., Zhang, Y., & Zhang, W. (2024). Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer. Current Treatment Options in Oncology. https://doi.org/10.1007/s11864-024-01243-y

Vancouver

Yue S, Zhang Y, Zhang W. Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer. Current Treatment Options in Oncology. 2024. doi:10.1007/s11864-024-01243-y

BibTeX
@article{Yue2024,
  author = {Yue, Shiwei and Zhang, Yunpu and Zhang, Wei},
  title = {Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer},
  journal = {Current Treatment Options in Oncology},
  year = {2024},
  doi = {10.1007/s11864-024-01243-y}
}
Kostenlos starten →